APROVEL 300MG
Code : APR02
Price:
Contact
Present/Packing Aprovel film-coated tablet
Aprovel 150 mg x 28's
Aprovel 300 mg x 28's
Delivery
Share this product to others
Shopping
guide
Add to cart
Share this product to friends and family
APROVEL
Manufacturer:
Sanofi-Aventis
Contents:
Irbesartan
Indications:
Essential HTN. Treatment of renal disease in patients w/ HTN & type 2 DM as part of an antihypertensive drug regimen.
Contraindications:
Pregnancy & lactation.
Special Precautions:
Increased risk of severe hypotension in
patients w/ renal artery stenosis. Periodic monitoring of K & serum
creatinine in patients w/ renal impairment. Monitoring of serum K in
patients, suffering from heart failure. Patients w/ recent kidney
transplantation, primary aldosteronism, aortic or mitral stenosis,
obstructive hypertrophic cardiomyopathy, ischaemic cardiopathy or
ischaemic CV disease.
Dosage:
Initial
& maintenance dose: 150 mg once daily. May be increased to 300 mg or other
antihypertensive agents can be added. In vol-depleted patients, correct prior
to administration. Elderly >75 yr & haemodialysis patients Consider
initiating w/ 75 mg. Hypertensive type 2 diabetic patients Initially 150 mg once
daily. Maintenance: 300 mg once daily.
Class:
Angiotensin
II Antagonists
Presentation/Packing:
Aprovel film-coated tablet
Aprovel 150 mg x 28's
Aprovel 300 mg x 28's
Details:
MyPhuocPharmacy – (08) 62581003
Irbesartan
Initial
& maintenance dose: 150 mg once daily. May be increased to 300 mg or other
antihypertensive agents can be added. In vol-depleted patients, correct prior
to administration. Elderly >75 yr & haemodialysis patients Consider
initiating w/ 75 mg. Hypertensive type 2 diabetic patients Initially 150 mg once
daily. Maintenance: 300 mg once daily.
Updating
Increased risk of severe hypotension in
patients w/ renal artery stenosis. Periodic monitoring of K & serum
creatinine in patients w/ renal impairment. Monitoring of serum K in
patients, suffering from heart failure. Patients w/ recent kidney
transplantation, primary aldosteronism, aortic or mitral stenosis,
obstructive hypertrophic cardiomyopathy, ischaemic cardiopathy or
ischaemic CV disease.